Stock Research: Healius

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Healius

ASX:HLS AU0000033359
6
  • Value
    48
  • Growth
    77
  • Safety
    Safety
    1
  • Combined
    29
  • Sentiment
    20
  • 360° View
    360° View
    6
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Healius Limited is a healthcare company providing specialized pathology services across Australia. It operates in healthcare services, offering pathology services through brands like QML, Laverty, Dorevitch, and others. It operates in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia, Northern Territory, Tasmania, and South Australia. In the last fiscal year, the company had 10500 employees, a market cap of $357 million, profits of $1015 million, and revenue of $1164 million.

more
Index
ASX 300
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
48 37 63 83
Growth
77 9 5 79
Safety
Safety
1 1 6 6
Sentiment
20 1 1 56
360° View
360° View
6 1 4 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
1 3 5 71
Opinions Change
61 35 6 50
Pro Holdings
n/a 3 13 66
Market Pulse
13 6 3 10
Sentiment
20 1 1 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
48 37 63 83
Growth
77 9 5 79
Safety Safety
1 1 6 6
Combined
29 1 4 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
84 79 83 71
Price vs. Earnings (P/E)
25 5 27 95
Price vs. Book (P/B)
68 83 93 69
Dividend Yield
45 16 36 62
Value
48 37 63 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 1 39 4
Profit Growth
98 18 8 98
Capital Growth
85 18 24 45
Stock Returns
32 67 3 87
Growth
77 9 5 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 5 8 14
Refinancing
4 4 6 6
Liquidity
21 10 16 17
Safety Safety
1 1 6 6

Similar Stocks

Discover high‑ranked alternatives to Healius and broaden your portfolio horizons.

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Medium
Full Stock Analysis

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: